Martin Mattingly Insider Profile
4 Followers
Martin Mattingly, Director at Achieve Life Sciences, holds 0.00 shares in TRACON Pharmaceuticals (Ticker: TCON), holds 8.00K shares in Achieve Life Sciences (Ticker: QUIT), holds 0.00 shares in Synageva (Ticker: GEVA).
Martin Mattingly's Trading History
| TCONTRACON Pharmaceuticals | Jun 02, 2016 | ― | Uninformative Buy | ― | $0.00 | |
| QUITAchieve Life Sciences | May 24, 2016 | Director | Uninformative Buy | 2.23K | $48.48K | |
| GEVASynageva | ― | ― | ― | ― |
You May Also Like
Martin Mattingly insider profile FAQ
What is the percentage of profitable transactions made by Martin Mattingly?
The percentage of profitable transactions made by Martin Mattingly is 0%.
What is the average return per transaction made by Martin Mattingly?
The average return per transaction made by Martin Mattingly is -41.00%.
What stocks does Martin Mattingly hold?
Martin Mattingly holds: QUIT, TCON, GEVA stocks.
What was Martin Mattingly's most profitable transaction?
Martin Mattingly’s most profitable transaction was an Informative Buy of QUIT stock on June 4, 2012. The return on the trade was -20.80%.
What is Martin Mattingly's role in Achieve Life Sciences?
Martin Mattingly's role in Achieve Life Sciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
